The adverse effect of hydrosalpinges on in vitro fertilization pregnancy rates and the benefit of surgical correction
- PMID: 9457930
- DOI: 10.1016/s0015-0282(97)00447-0
The adverse effect of hydrosalpinges on in vitro fertilization pregnancy rates and the benefit of surgical correction
Abstract
Objective: To test the hypothesis that IVF-ET pregnancy rates (PRs) for patients with tubal factor infertility are decreased in patients with hydrosalpinges and that surgical correction reverses this effect.
Design: Retrospective chart review.
Setting: Private practice IVF-ET program.
Patient(s): Patients (n = 160) undergoing 238 cycles of IVF-ET were stratified into groups based on the presence of hydrosalpinges and whether surgical correction had been performed. Patients >39 years old and patients with male factor infertility were excluded from the study.
Intervention(s): Patients with hydrosalpinges were offered surgical correction.
Main outcome measure(s): Clinical pregnancy defined by an intrauterine gestational sac.
Result(s): Patients with hydrosalpinges had significantly decreased implantation rates and PRs per transfer (2.8% and 8.5%, respectively) than patients with tubal factor infertility but without hydrosalpinges (15.7% and 38.6%). Surgical correction improved implantation rates and PRs in patients with prior failed cycles (16.1% and 37.5%) and in patients undergoing surgery before IVF-ET (21.8% and 51.7%). The type of surgery performed did not affect success rates in the small number of patients evaluated.
Conclusion(s): The presence of a hydrosalpinx during an IVF-ET cycle results in significant decreases in implantation rates and PRs. Surgical treatment of hydrosalpinges before IVF-ET cycles improves implantation rates and PRs.
Similar articles
-
The significance of hydrosalpinx in in vitro fertilization.Fertil Steril. 1998 Mar;69(3):373-84. doi: 10.1016/s0015-0282(97)00484-6. Fertil Steril. 1998. PMID: 9531862 Review.
-
Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion.Fertil Steril. 2001 Mar;75(3):612-7. doi: 10.1016/s0015-0282(00)01742-8. Fertil Steril. 2001. PMID: 11239550
-
Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates.Am J Obstet Gynecol. 2000 Aug;183(2):367-71. doi: 10.1067/mob.2000.107671. Am J Obstet Gynecol. 2000. PMID: 10942471
-
Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature.Hum Reprod. 1995 Mar;10(3):576-9. doi: 10.1093/oxfordjournals.humrep.a135992. Hum Reprod. 1995. PMID: 7782435 Clinical Trial.
-
How to treat hydrosalpinges: IVF as the treatment of choice.Reprod Biomed Online. 2002;4 Suppl 3:37-9. doi: 10.1016/s1472-6483(12)60114-x. Reprod Biomed Online. 2002. PMID: 12470563 Review.
Cited by
-
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD002125. doi: 10.1002/14651858.CD002125.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2020 Oct 22;10:CD002125. doi: 10.1002/14651858.CD002125.pub4. PMID: 20091531 Free PMC article. Updated.
-
Ultrasound guided aspiration of hydrosalpinx fluid versus salpingectomy in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET: a randomized controlled trial.BMC Womens Health. 2015;15:21. doi: 10.1186/s12905-015-0177-2. Epub 2015 Feb 27. BMC Womens Health. 2015. PMID: 25783650 Free PMC article. Clinical Trial.
-
Effects of hydrosalpingeal fluid on murine embryo development and implantation.J Assist Reprod Genet. 1999 Sep;16(8):421-4. doi: 10.1023/a:1020517524857. J Assist Reprod Genet. 1999. PMID: 10478321 Free PMC article.
-
Comparison of the efficacy between bilateral proximal tubal occlusion and total salpingectomy on ovarian reserve and the cholinergic system: an experimental study.Turk J Med Sci. 2020 Jun 23;50(4):1097-1105. doi: 10.3906/sag-2002-179. Turk J Med Sci. 2020. PMID: 32394684 Free PMC article.
-
Progesterone and Inflammatory Response in the Oviduct during Physiological and Pathological Conditions.Cells. 2022 Mar 23;11(7):1075. doi: 10.3390/cells11071075. Cells. 2022. PMID: 35406639 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources